Journal
PHYTOMEDICINE
Volume 18, Issue 12, Pages 1056-1069Publisher
ELSEVIER GMBH
DOI: 10.1016/j.phymed.2011.03.004
Keywords
Antileishmanial; Amastigotes; Plant derived compounds
Categories
Funding
- Indian Council of Medical Research, Govt. of India
- Indian Council of Medical Research (ICMR)
- Council for Scientific and Industrial Research (CSIR)
- Dept. of Science and Technology (DST), Govt. of India
Ask authors/readers for more resources
Diseases caused by insect borne trypanosomatid parasites are significant, yet remain a neglected public health problem. Leishmania, a unicellular protozoan parasite is the causative organism of Leishmaniasis and is transmitted by female phlebotamine sandflies affecting millions of people worldwide. In the wake of resistance to pentavalent antimonial drugs, new therapeutic alternatives are desirable. The plant kingdom has in the past provided several affordable compounds and this review aims to provide an overview of the current status of available leishmanicidal plant derived compounds that are effective singly or in combination with conventional anti-leishmanial drugs, yet are non toxic to mammalian host cells. Furthermore, delineation of the contributory biochemical mechanisms involved in mediating their effect would help develop new chemotherapeutic approaches. (C) 2011 Elsevier GmbH. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available